Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Hydration and symptoms in the last days of life.

Lokker ME, van der Heide A, Oldenmenger WH, van der Rijt CCD, van Zuylen L.

BMJ Support Palliat Care. 2019 Aug 31. pii: bmjspcare-2018-001729. doi: 10.1136/bmjspcare-2018-001729. [Epub ahead of print]

PMID:
31473651
2.

Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".

van Esch HJ, Geijteman ECT, van der Rijt CCD.

J Pain Symptom Manage. 2019 Apr;57(4):e1-e2. doi: 10.1016/j.jpainsymman.2019.01.004. Epub 2019 Jan 17. No abstract available.

PMID:
30660674
3.

Correction: Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study.

Brinkman-Stoppelenburg A, Witkamp FE, van Zuylen L, van der Rijt CCD, van der Heide A.

PLoS One. 2018 Nov 29;13(11):e0208564. doi: 10.1371/journal.pone.0208564. eCollection 2018.

4.

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.

Kuip EJM, Oldenmenger WH, Oomen-de Hoop E, Verduijn GM, Thijs-Visser MF, de Bruijn P, van Meerten E, Koolen SLW, Mathijssen RHJ, van der Rijt CCD.

Cancers (Basel). 2018 Nov 15;10(11). pii: E445. doi: 10.3390/cancers10110445.

5.

Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients.

Bechakra M, Moerdijk F, van Rosmalen J, Koch BCP, van der Rijt CCD, Sillevis Smitt PAE, Jongen JLM.

Eur J Cancer. 2018 Dec;105:79-87. doi: 10.1016/j.ejca.2018.09.036. Epub 2018 Nov 12.

PMID:
30439627
6.

Scopolaminebutyl given prophylactically for death rattle: study protocol of a randomized double-blind placebo-controlled trial in a frail patient population (the SILENCE study).

van Esch HJ, van Zuylen L, Oomen-de Hoop E, van der Heide A, van der Rijt CCD.

BMC Palliat Care. 2018 Sep 7;17(1):105. doi: 10.1186/s12904-018-0359-4.

7.

Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study.

Brinkman-Stoppelenburg A, Witkamp FE, van Zuylen L, van der Rijt CCD, van der Heide A.

PLoS One. 2018 Aug 23;13(8):e0201191. doi: 10.1371/journal.pone.0201191. eCollection 2018. Erratum in: PLoS One. 2018 Nov 29;13(11):e0208564.

8.

Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer.

Kuip EJM, Oldenmenger WH, Thijs-Visser MF, de Bruijn P, Oosten AW, Oomen-de Hoop E, Koolen SLW, Van der Rijt CCD, Mathijssen RHJ.

PLoS One. 2018 Jun 8;13(6):e0198289. doi: 10.1371/journal.pone.0198289. eCollection 2018.

9.

Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl.

Kuip EJM, Oldenmenger WH, Visser-Thijs MF, de Bruijn P, Oomen-de Hoop E, Mathijssen RHJ, Van der Rijt CCD, Koolen SW.

Oncotarget. 2018 Apr 6;9(26):18269-18276. doi: 10.18632/oncotarget.24812. eCollection 2018 Apr 6.

10.

Medication Discontinuation at the End of Life: A Questionnaire Study on Physicians' Experiences and Opinions.

Geijteman ECT, Huisman BAA, Dees MK, Perez RSGM, van der Rijt CCD, van Zuylen L, van der Heide A.

J Palliat Med. 2018 Aug;21(8):1166-1170. doi: 10.1089/jpm.2017.0501. Epub 2018 Apr 18.

PMID:
29668346
11.

Interventions in hospitalised patients with cancer: the importance of impending death awareness.

Geijteman ECT, Graaf MV, Witkamp FE, Norden SV, Stricker BH, van der Rijt CCD, van der Heide A, van Zuylen L.

BMJ Support Palliat Care. 2018 Sep;8(3):278-281. doi: 10.1136/bmjspcare-2017-001466. Epub 2018 Feb 9.

PMID:
29440148
12.

Feasibility and validity of a tool for identification of people with intellectual disabilities in need of palliative care (PALLI).

Vrijmoeth C, Groot CM, Christians MGM, Assendelft WJJ, Festen DAM, van der Rijt CCD, van Schrojenstein Lantman-de Valk HMJ, Vissers KCP, Echteld MA.

Res Dev Disabil. 2018 Jan;72:67-78. doi: 10.1016/j.ridd.2017.10.020. Epub 2017 Nov 5.

PMID:
29107852
13.

Development and feasibility of a web application to monitor patients' cancer-related pain.

Oldenmenger WH, Baan MAG, van der Rijt CCD.

Support Care Cancer. 2018 Feb;26(2):635-642. doi: 10.1007/s00520-017-3877-3. Epub 2017 Sep 19.

14.

Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry.

Thong MSY, Mols F, van de Poll-Franse LV, Sprangers MAG, van der Rijt CCD, Barsevick AM, Knoop H, Husson O.

J Cancer Surviv. 2018 Feb;12(1):38-46. doi: 10.1007/s11764-017-0641-0. Epub 2017 Sep 9.

PMID:
28889367
15.

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.

Aarts MJ, Vriens BE, de Boer M, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Tol J, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, van der Rijt CCD, Smilde TJ, van der Velden AW, Peer N, Tjan-Heijnen VCG.

Oncology. 2017;93(5):323-328. doi: 10.1159/000479067. Epub 2017 Aug 22.

PMID:
28848182
16.

Is there a role for pharmacogenetics in the dosing of fentanyl?

Koolen SL, Van der Rijt CC.

Pharmacogenomics. 2017 Apr;18(5):417-419. doi: 10.2217/pgs-2017-0022. Epub 2017 Mar 27. No abstract available.

17.

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.

Oosten AW, Abrantes JA, Jönsson S, Matic M, van Schaik RHN, de Bruijn P, van der Rijt CCD, Mathijssen RHJ.

Clin Pharmacokinet. 2017 Jul;56(7):733-746. doi: 10.1007/s40262-016-0471-7.

18.

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Kuip EJ, Zandvliet ML, Koolen SL, Mathijssen RH, van der Rijt CC.

Br J Clin Pharmacol. 2017 Feb;83(2):294-313. doi: 10.1111/bcp.13129. Epub 2016 Oct 29. Review.

19.

Adherence to Analgesics in Oncology Outpatients: Focus on Taking Analgesics on Time.

Oldenmenger WH, Sillevis Smitt PAE, de Raaf PJ, van der Rijt CCD.

Pain Pract. 2017 Jun;17(5):616-624. doi: 10.1111/papr.12490. Epub 2016 Oct 14.

PMID:
27739244
20.

Physician-Reported Symptoms and Interventions in People with Intellectual Disabilities Approaching End of Life.

Vrijmoeth C, Christians MG, Festen DA, Groot M, van der Heide A, van der Rijt CC, Tonino M, Echteld MA.

J Palliat Med. 2016 Nov;19(11):1142-1147. Epub 2016 Sep 1.

PMID:
27585357
21.

Feasibility of assessing patients' acceptable pain in a randomized controlled trial on a patient pain education program.

Oldenmenger WH, van der Rijt CC.

Palliat Med. 2017 Jun;31(6):553-558. doi: 10.1177/0269216316664492. Epub 2016 Aug 9.

PMID:
27507634
22.

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

Oosten AW, Matic M, van Schaik RH, Look MP, Jongen JL, Mathijssen RH, van der Rijt CC.

Pharmacogenomics. 2016 Aug;17(13):1391-403. doi: 10.2217/pgs-2016-0082. Epub 2016 Jul 29. Erratum in: Pharmacogenomics. 2017 May;18(7):743-748.

PMID:
27472837
23.

To be in pain (or not): a computer enables outpatients to inform their physician.

Oldenmenger WH, Witkamp FE, Bromberg JE, Jongen JL, Lieverse PJ, Huygen FJ, Baan MA, van Zuylen L, van der Rijt CC.

Ann Oncol. 2016 Sep;27(9):1776-81. doi: 10.1093/annonc/mdw250. Epub 2016 Jul 20.

PMID:
27443633
24.

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients.

Oosten AW, Abrantes JA, Jönsson S, de Bruijn P, Kuip EJ, Falcão A, van der Rijt CC, Mathijssen RH.

Eur J Clin Pharmacol. 2016 Apr;72(4):459-67. doi: 10.1007/s00228-015-2005-x. Epub 2016 Jan 14.

25.

A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures.

Oosten AW, Oldenmenger WH, Mathijssen RH, van der Rijt CC.

J Pain. 2015 Oct;16(10):935-46. doi: 10.1016/j.jpain.2015.05.006. Epub 2015 Jun 5. Review.

PMID:
26051219
26.

Effect of palliative care nurse champions on the quality of dying in the hospital according to bereaved relatives: A controlled before-and-after study.

Witkamp FE, van Zuylen L, van der Rijt CC, van der Heide A.

Palliat Med. 2016 Feb;30(2):180-8. doi: 10.1177/0269216315588008. Epub 2015 May 19.

PMID:
25991728
27.

Problems and needs in patients with incurable esophageal and pancreaticobiliary cancer: a descriptive study.

Uitdehaag MJ, Verschuur EM, van Eijck CH, van der Gaast A, van der Rijt CC, de Man RA, Steyerberg EW, Kuipers EJ, Siersema PD.

Gastroenterol Nurs. 2015 Jan-Feb;38(1):42-54. doi: 10.1097/SGA.0000000000000088.

PMID:
25636012
28.

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.

Taal W, van der Rijt CC, Dinjens WN, Sillevis Smitt PA, Wertenbroek AA, Bromberg JE, van Heuvel I, Kros JM, van den Bent MJ.

J Neurooncol. 2015 Jan;121(2):365-72. doi: 10.1007/s11060-014-1641-9. Epub 2014 Oct 26.

PMID:
25344884
29.

Dying in the hospital: what happens and what matters, according to bereaved relatives.

Witkamp FE, van Zuylen L, Borsboom G, van der Rijt CC, van der Heide A.

J Pain Symptom Manage. 2015 Feb;49(2):203-13. doi: 10.1016/j.jpainsymman.2014.06.013. Epub 2014 Aug 15.

PMID:
25131893
30.

Is physician awareness of impending death in hospital related to better communication and medical care?

Houttekier D, Witkamp FE, van Zuylen L, van der Rijt CC, van der Heide A.

J Palliat Med. 2014 Nov;17(11):1238-43. doi: 10.1089/jpm.2014.0203. Epub 2014 Aug 12.

PMID:
25115220
31.

Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.

Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Joore MA, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4283-9. doi: 10.1200/JCO.2012.48.3644. Epub 2013 Oct 28.

PMID:
24166522
32.

Can you help me feel less exhausted all the time?

de Raaf PJ, van der Rijt CC.

J Clin Oncol. 2013 Sep 1;31(25):3056-60. doi: 10.1200/JCO.2013.49.3403. Epub 2013 Jul 29.

PMID:
23897965
33.

Nurse-led follow-up at home vs. conventional medical outpatient clinic follow-up in patients with incurable upper gastrointestinal cancer: a randomized study.

Uitdehaag MJ, van Putten PG, van Eijck CH, Verschuur EM, van der Gaast A, Pek CJ, van der Rijt CC, de Man RA, Steyerberg EW, Laheij RJ, Siersema PD, Spaander MC, Kuipers EJ.

J Pain Symptom Manage. 2014 Mar;47(3):518-30. doi: 10.1016/j.jpainsymman.2013.04.006. Epub 2013 Jul 20.

PMID:
23880585
34.

Validation of the Rotterdam MOVE2PC Questionnaire for assessment of nurses' knowledge and opinions on palliative care.

Witkamp FE, van Zuylen L, van der Rijt CC, van der Heide A.

Res Nurs Health. 2013 Oct;36(5):512-23. doi: 10.1002/nur.21551. Epub 2013 Jun 27.

PMID:
23813723
35.

Prevalence, impact, and treatment of death rattle: a systematic review.

Lokker ME, van Zuylen L, van der Rijt CC, van der Heide A.

J Pain Symptom Manage. 2014 Jan;47(1):105-22. doi: 10.1016/j.jpainsymman.2013.03.011. Epub 2013 Jun 18. Review.

PMID:
23790419
36.

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4290-6. doi: 10.1200/JCO.2012.44.6229. Epub 2013 Apr 29.

PMID:
23630211
37.

Improving the quality of palliative and terminal care in the hospital by a network of palliative care nurse champions: the study protocol of the PalTeC-H project.

Witkamp FE, van Zuylen L, van der Maas PJ, van Dijk H, van der Rijt CC, van der Heide A.

BMC Health Serv Res. 2013 Mar 25;13:115. doi: 10.1186/1472-6963-13-115.

38.

The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.

Jongen JL, Huijsman ML, Jessurun J, Ogenio K, Schipper D, Verkouteren DR, Moorman PW, van der Rijt CC, Vissers KC.

J Pain Symptom Manage. 2013 Oct;46(4):581-590.e1. doi: 10.1016/j.jpainsymman.2012.10.230. Epub 2013 Feb 12. Review.

PMID:
23415040
39.

Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial.

de Raaf PJ, de Klerk C, Timman R, Busschbach JJ, Oldenmenger WH, van der Rijt CC.

J Clin Oncol. 2013 Feb 20;31(6):716-23. doi: 10.1200/JCO.2012.44.4216. Epub 2013 Jan 2.

PMID:
23284036
40.

Elucidating the behavior of physical fatigue and mental fatigue in cancer patients: a review of the literature.

de Raaf PJ, de Klerk C, van der Rijt CC.

Psychooncology. 2013 Sep;22(9):1919-29. doi: 10.1002/pon.3225. Epub 2012 Nov 13. Review.

PMID:
23147803
41.

Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review.

Oldenmenger WH, de Raaf PJ, de Klerk C, van der Rijt CC.

J Pain Symptom Manage. 2013 Jun;45(6):1083-93. doi: 10.1016/j.jpainsymman.2012.06.007. Epub 2012 Sep 25. Review.

PMID:
23017617
42.

Differences in fatigue experiences among patients with advanced cancer, cancer survivors, and the general population.

de Raaf PJ, de Klerk C, Timman R, Hinz A, van der Rijt CC.

J Pain Symptom Manage. 2012 Dec;44(6):823-30. doi: 10.1016/j.jpainsymman.2011.12.279. Epub 2012 Jul 13.

PMID:
22795903
43.

Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study.

de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC.

Cancer. 2012 Dec 1;118(23):6005-11. doi: 10.1002/cncr.27613. Epub 2012 Jun 26.

44.

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

Taal W, Segers-van Rijn JM, Kros JM, van Heuvel I, van der Rijt CC, Bromberg JE, Sillevis Smitt PA, van den Bent MJ.

J Neurooncol. 2012 May;108(1):195-200. doi: 10.1007/s11060-012-0832-5. Epub 2012 Mar 7.

45.

Effectiveness of a multidisciplinary consultation team for cancer pain and palliative care in a large university hospital in The Netherlands.

Jongen JL, Overbeck A, Stronks DL, van Zuylen L, Booms M, Huygen FJ, van der Rijt CC.

BMJ Support Palliat Care. 2011 Dec;1(3):322-8. doi: 10.1136/bmjspcare-2011-000087. Epub 2011 Oct 9.

PMID:
24653478
46.

A combined pain consultation and pain education program decreases average and current pain and decreases interference in daily life by pain in oncology outpatients: a randomized controlled trial.

Oldenmenger WH, Sillevis Smitt PA, van Montfort CA, de Raaf PJ, van der Rijt CC.

Pain. 2011 Nov;152(11):2632-9. doi: 10.1016/j.pain.2011.08.009. Epub 2011 Sep 8.

PMID:
21906879
47.

Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids.

Oldenmenger WH, Lieverse PJ, Janssen PJ, Taal W, van der Rijt CC, Jager A.

Support Care Cancer. 2012 Aug;20(8):1639-47. doi: 10.1007/s00520-011-1254-1. Epub 2011 Aug 23.

48.

Higher doses of opioids in patients who need palliative sedation prior to death: cause or consequence?

Oosten AW, Oldenmenger WH, van Zuylen C, Schmitz PI, Bannink M, Lieverse PJ, Bromberg JE, van der Rijt CC.

Eur J Cancer. 2011 Oct;47(15):2341-6. doi: 10.1016/j.ejca.2011.06.057. Epub 2011 Jul 26.

49.

Awareness of dying: it needs words.

Lokker ME, van Zuylen L, Veerbeek L, van der Rijt CC, van der Heide A.

Support Care Cancer. 2012 Jun;20(6):1227-33. doi: 10.1007/s00520-011-1208-7. Epub 2011 Jun 19.

50.

Survey on the prevalence of pain in Dutch district nursing care.

Baan MA, Mesa AA, Adriaens-van der Steen AL, van der Rijt CC.

J Palliat Med. 2011 Jun;14(6):696-9. doi: 10.1089/jpm.2010.0537. Epub 2011 May 6.

PMID:
21548791

Supplemental Content

Loading ...
Support Center